Increased risk of young-onset pancreatic cancer among adults aged 20-39 years with overweight or obesity, but not underweight: A nationwide cohort study

Colonoscopy

Colorectal cancer incidence following a negative colonoscopy in fecal immunochemical test-based screening: a nationwide cohort study after 8 years of screening in Denmark

Endoscopy

Larsen PT, Jørgensen SF, Rasmussen M, Andersen B, Cross AJ, Njor SH

doi: 10.1055/a-2551-1471

Gastrointestinal Cancer

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Cancer Epidemiol Biomarkers Prev

Peila R, Manson JE, Rohan TE

doi: 10.1158/1055-9965.EPI-25-0745

Inflammatory Bowel Disease

Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study

Clin Gastroenterol Hepatol

Ben Hur D, Issaschar G, Moshe R, Lebedenko B, Lujan R, Haklai Z, Weisband YL, Ben-Tov A, Lederman N, Matz E, Dotan I, Turner D, Pinto GD, Waterman M

doi: 10.1016/j.cgh.2025.01.020

Gastrointestinal CancerInflammatory Bowel Disease

Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Inflamm Bowel Dis

Huang YJ, Lin JA, Chen WM, Shia BC, Wu SY

doi: 10.1093/ibd/izaf304

Inflammatory Bowel Disease

Microscopic colitis and risk of venous thromboembolism: A nationwide matched cohort study

Am J Gastroenterol

Forss A, Bröms G, Bergman D, Thuresson M, Sun J, Eriksson C, Olén O, Zöller B, Ludvigsson JF

doi: 10.14309/ajg.0000000000003408

Hepatology

Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Hepatology

Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A

doi: 10.1097/HEP.0000000000001351

Hepatology

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

BMC Gastroenterol

Shin WY, Kang ES, Oh YH, Sha M, Xia Q, Jeong S, Cho Y

doi: 10.1186/s12876-025-03814-1

Pancreas Diseases

Risk factor analysis and nomogram development for survival prediction in obese patients with severe acute pancreatitis: a retrospective study

BMC Gastroenterol

Zhu Q, Shan X, Tan D, Lu M, Xu Y

doi: 10.1186/s12876-025-04266-3

Gastrointestinal Cancer

Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021

BMC Gastroenterol

Yue B, Lu Z, Zong D, Hu Y, Yang Z

doi: 10.1186/s12876-025-04432-7

Related content

Colorectal cancer incidence following a negative colonoscopy in fecal immunochemical test-based screening: a nationwide cohort study after 8 years of screening in Denmark

Risk factors for pancreatic cancer among non-smokers and non-drinkers of alcohol in the Women's Health Initiative

Risk of age-related and disease-related complications and mortality in elderly-onset IBD - a population-based study

Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study

Microscopic colitis and risk of venous thromboembolism: A nationwide matched cohort study

Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk

Risk factor analysis and nomogram development for survival prediction in obese patients with severe acute pancreatitis: a retrospective study

Global, regional, and national burden of early-onset and late-onset colorectal cancer attributable to high body-mass index from 1990 to 2021: a trend analysis and forecasts up to 2040 based on the global burden of disease study 2021